|
Time to Licensure (years) |
Time to Adoption (years) |
Efficacy |
Number of doses |
Cost per dose (dollars) |
|
3 |
2–5 (dependent on price) |
0.99 |
3–5 |
10 |
|
3 |
2–5 (dependent on price) |
0.95 |
3–5 |
10 |
|
3 |
2 |
0.95 |
1 |
1 |
|
5 |
2 |
0.80 (against severe disease in young children) |
2+booster |
15 |
|
5 |
2 |
0.80 (against severe disease in young children) |
1–2 |
15 |
|
2 |
2 |
0.80 (against severe disease in young children) |
1 |
10 |
|
5 |
2 |
0.90 (against severe disease in young children) |
1 |
10 |
|
5 |
2 |
0.90 (against severe disease in young children) |
1 |
10 |
|
1 |
2 (endemic areas) |
0.80 |
2–3 |
2 |
|
5–8 |
|
0.80–0.90 |
2–3 |
2 |
|
approx. 10 |
2 |
0.80–0.90 (for a multivalent vaccine) |
1–2 |
2 |
|
6–8 |
2–5 |
0.80 (depends on adjuvant or carrier development) |
2 |
5 |
|
5 |
2 |
0.80 |
1–2 |
20 |
|
5–7 |
2 |
0.90 |
1–2 |
2 |
|
3–5 |
2 |
0.65 |
2–3 |
2 |
|
2–4 |
2 (endemic areas) |
0.90 |
1 |
5 |